Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Feasibility study of perioperative chemoradiotherapy with irinotecan and 5-fluorouracil for gastric adenocarcinoma
2006-005576-40Phase 2Completed
- Sponsor
- Rouen University Hospital
- Start
- Feb 2007
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of irinotecan, fluorouracil and folinic acid in gastric adenocarcinoma (2 arms), sponsored by Rouen University Hospital. Primary endpoint: Completion of full therapeutic sequence. Started Feb 2007; status: completed.
02
Drugs
irinotecanfluorouracilfolinic acid
03
Conditions
gastric adenocarcinoma
Beyond the preview
Go deeper on 2006-005576-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-005576-40.